INS and osteoporosis: PPARγ activation has a robust insulin sensitizing effect, making TZDs potent insulin sensitizers and highly effective oral medications for type 2 diabetes, although, their clinical use is limited by major adverse effects including weight gain, fluid retention, and osteoporosis (Ahmadian et al., 2013).